A charity’s e-learning module can help people in West Lothian who are receiving support for alcohol and drug use to live ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Monday revealed new animal study results from SKNY-1, a next-generation oral ...

E-cigarettes have become increasingly popular over the last two decades, especially among young people. These sleek, ...

While the percentage of teens who vape peaked around 2019 and has since declined, an important shift has occurred in that ...

When John,* 43, first heard about Zyn from a friend a couple years ago, it struck him as a “much better alternative to ...

MIRA's to be acquired SKNY-1 cut weight and food cravings in animals, reversed liver fat, and reduced nicotine desire—without triggering muscle loss or overstimulation.

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved ...

The group was oversampled for tobacco use, with 1:1 sampling quotas by age group (55.6% adolescent vs young adult) and ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

MIRA Pharmaceuticals (NASDAQ: MIRA) shares soared 50.8% to $1.87 in after-hours trading on Wednesday after announcing promising results for their non-opioid pain drug, Mira-55, and plans for future ...

Turns out the disposable nicotine delivery systems are, as suspected, worse than the real thing, according to a new study ...